A research team from the University of Southern California (USC) has found that a blood test can detect nano-sized signs of early-stage breast cancer.
Conducted in a small group of patients, the study showed that the liquid biopsy can determine whether a patient has breast cancer in the early stages, as well as the unlikelihood of the disease returning.
The study was conducted in partnership between USC, Epic Sciences, Duke University, Billings Clinic and the USC Norris Comprehensive Cancer Center.
